Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/PALI/Capital expenditures

PALISADE BIO, INC. (PALI) Capital expenditures 2016–2024

PALISADE BIO, INC. (PALI) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$0FY2024 · since FY2016: $98,088 → $0
1617182021222324
Fiscal yearValueYoY
FY2024$0-100.0%
FY2023$4,000-60.0%
FY2022$10,000—
FY2021$0-100.0%
FY2020$6,000—
FY2018$1,714-85.0%
FY2017$11,401-88.4%
FY2016$98,088—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More PALI financial trends

PALI RevenuePALI Net incomePALI Net marginPALI Gross profitPALI Gross marginPALI Operating incomePALI Operating marginPALI Operating cash flowPALI Free cash flowPALI Return on equityPALI Stock buybacksPALI Dividends paidPALI Total assetsPALI Total liabilitiesPALI Shareholders’ equityPALI overview →